Geron Corporation
GERN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $47 | $49 | $40 | $48 |
| % Growth | -3.7% | 23.8% | -16.7% | – |
| Cost of Goods Sold | $22 | $1 | $1 | $1 |
| Gross Profit | $25 | $48 | $38 | $47 |
| % Margin | 53.2% | 97.6% | 97% | 98.4% |
| R&D Expenses | $21 | $22 | $15 | $23 |
| G&A Expenses | $0 | $0 | $40 | $43 |
| SG&A Expenses | $39 | $39 | $40 | $43 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$21 | $0 | $0 | $0 |
| Operating Expenses | $39 | $60 | $55 | $67 |
| Operating Income | -$14 | -$12 | -$17 | -$20 |
| % Margin | -29.4% | -25.4% | -42.2% | -42.2% |
| Other Income/Exp. Net | -$5 | -$4 | -$3 | -$5 |
| Pre-Tax Income | -$18 | -$16 | -$20 | -$25 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$18 | -$16 | -$20 | -$25 |
| % Margin | -39% | -33.4% | -50.1% | -53.3% |
| EPS | -0.028 | -0.025 | -0.03 | -0.039 |
| % Growth | -12.2% | 18% | 23.5% | – |
| EPS Diluted | -0.028 | -0.025 | -0.03 | -0.039 |
| Weighted Avg Shares Out | 667 | 666 | 666 | 646 |
| Weighted Avg Shares Out Dil | 667 | 666 | 666 | 646 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $5 | $5 | $5 |
| Interest Expense | $9 | $9 | $8 | $9 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$10 | -$8 | -$11 | -$16 |
| % Margin | -20.4% | -15.4% | -28.6% | -34.4% |